Clinico-demographic characteristics of the patients with decompensated chronic heart failure Clinico-demographic characteristics of the patients with decompensated chronic heart failure
https://doi.org/10.15829/1728-8800-2011-2-75-80
Abstract
Aim. To study clinico-demographical characteristics of the patients with decompensated chronic heart failure (CHF).
Material and methods. The analysis included the data of 112 patients hospitalised at Moscow City Clinical Hospital No. 68 due to decompensated CHF. The follow-up period lasted 30 days.
Results. The mean age of the patients (33 % men, 67 % women) was 70,3±9,9 years. Older age (>70 years) was significantly more prevalent in women than in men (р=0,005). The main reason for CHF decompensation was inadequate pre-hospital therapy. The mean duration of the in-hospital treatment was 17,5±6,4 days. The level of 30-day fatality was 12,5 % (n=14). According to correlation analysis results, systolic blood pressure (SBP) level <100 mm Hg positively correlated with 30-day fatality (r=0,4; р=0,0001). Hemoglobin level <100 g/l also positively correlated with 30-day fatality (r=0,3; р=0,05).
Conclusion. The prevalence of decompensated CHF is higher in women. Compared to men, women develop CHF in more advanced age. The main fatality-associated factors were low hemoglobin level, SBP <100 mm Hg, and age >70 years. The leading causes of death were pulmonary thromboembolism and diuretic therapy resistance.
About the Authors
S. N. Tereshchenko
Moscow State Medico-Stomatological University
Russian Federation
Moscow
Russian Federation
Moscow
I. V. Kositsyna
Moscow State Medico-Stomatological University
Russian Federation
Moscow
Russian Federation
Moscow
N. A. Dzhaiani
Moscow State Medico-Stomatological University
Russian Federation
Moscow
Russian Federation
Moscow
N. A. Gnidkina
Moscow State Medico-Stomatological University
Russian Federation
Moscow
Russian Federation
Moscow
A. V. Golubev
Moscow State Medico-Stomatological University
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Больные с хронической сердечной недостаточностью в российской амбулаторной практике: особенности контингента, диагностики и лечения (по материалам исследования ЭПОХАО-ХСН). Ж Серд недостат 2004; 5(1): 4-7.
2. Jessup M, and Brozena S. Heart Failure NEJM 2003; 348 (20): 2007-18.
3. Даниелян М.О. Прогноз и лечение хронической сердечной недостаточности (данные 20-и летнего наблюдения). Автореф дис канд мед наук. Москва.
4. O’Callaghan РА, Camm AJ. Treatment of arrhythmias in heart failure. Eur J Heart Failure 1999; 1(2): 133-7.
5. Reynolds R, Seckl JR, Hyponatraemia for the clinical endocrinologist, Clin Endocrinol (Oxf) 2005; 63: 366-74.
6. Мартынов А.И., Степура О.Б., Томлева Ф.Э. и др. Прогноз больных с хронической сердечной недостаточностью (по материалам XIX-XII конгрессов Европейского общества кардиологов). Тер архив 2002; 9: 70-3.
7. Upadhyay A, Jaber BL, Madias NE, Incidence and prevalence of hyponatremia. Am J Med 2006; 119(Suppl. 1): S30-5.
8. Kanu Chatterjee Analytic Review: Hyponatremia in Heart Failure Journal of Intensive Care Medicine 2009; 24(6): 347-51.
9. Gheorghiade M, Abraham WT, Albert NM, et al., Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007; 28(8): 980-8.
10. Sarnak M, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk In Communities (ARIC) study. JACC 2002; 40: 27-33.
11. Арутюнов Г.П. Анемия у больных с ХСН. Ж Серд недостат 2003; 4(5) (21): 224-8.
12. Komajds M, Anker SD, Charlesworth A, et al. for the COMET Investigators. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 2006; 27(12): 1440-6.
13. Cromie N, Lee C, Struthers AD. Anemia in chronic heart failure: what is the frequency in the UK and its underlying causes? Heart 2002; 87: 377-8.
14. Michael G, Shlipak, Barry M, et al. The Clinical Challenge of Cardiorenal Syndrome. Circulation 2004; 110: 1514-7.
15. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. JACC 2001; 37: 379-85.
16. Hall C. The value of natriuretic peptides for the management of heart failure: current state of play. Eur J Heart Fail 2001; 3: 395-7.
17. Ellison DH. Diuretic therapy and resistance in congestive heart failure Cardiology 2001; 96: 132-43.
Review
For citations:
Tereshchenko S.N., Kositsyna I.V., Dzhaiani N.A., Gnidkina N.A., Golubev A.V. Clinico-demographic characteristics of the patients with decompensated chronic heart failure Clinico-demographic characteristics of the patients with decompensated chronic heart failure. Cardiovascular Therapy and Prevention. 2011;10(2):75-80. (In Russ.) https://doi.org/10.15829/1728-8800-2011-2-75-80
Views:
586
Email this article 
